|
Group Profile
Group Structure
Business Review
Milestones
Honors
Cultures
Overseas Cooperation

 

Milestones

 
Year 2009
In January Dawnrays Pharma held a ground-breaking ceremony in Hedong Industrial Park, Wuzhong Economic Development District, Suzhou to lay the foundation stone of its new plant for system specific medicines.
In March Phase II of the construction project specialized for non-cephalosporin pharmaceutical intermediates of Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd. was officially fixed.
In April The construction project for oral cephalosporin bulk medicine workshop of Suzhou Dawnrays Chemical Co., Ltd. was officially fixed.
In May The four production workshops of Suzhou Dawnrays Pharmaceutical Co., Ltd. (including two cephalosporin bulk medicine workshops, one non-cephalosporin bulk medicine workshop and one solid pharmaceutical preparation workshop) successfully passed the Chinese GMP re-certification.
In September Dawnrays Pharma held a singing contest in celebration for the 60th anniversary of the founding of the P.R. China.
In September Mr. YAN Li, Mayor of Suzhou, together with other senior executives of the People’s Government of Suzhou made an inspection tour to Suzhou Dawnrays Pharmaceutical Co., Ltd. with respect to the safety of the production work.
In November Dawnrays Pharma held the sixth training camp for Managers.
Year 2008
In March Mr. ZHANG Weiguo, Deputy Governor of Jiangsu Province together with other senior executives of the People’s Government of Jiangsu Province visited Suzhou Dawnrays Pharmaceutical Co., Ltd.
In May Dawnrays Pharma made medicine and money donations totaling approximately RMB 137.5 million to the quake-stricken areas in Sichuan through the Chinese Red Cross Foundation and the Suzhou Red Cross Foundation.
In June Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the certification and assessment on three major management systems as conducted by Shanghai NQA Certification Co., Ltd. (SNQA), a renowned accredited certification body under National Quality Assurance (NQA), Limited.
In November Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd. held a ceremony in Nantong, Jiangsu Province to celebrate the grand opening of its newly constructed chemical plant.
In November Dawnrays Pharma held the fifth training camp for Managers.
In December The powder for injection workshop no. 202 of Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the Chinese GMP re-certification.
Year 2007
In February The sterile bulk medicine workshop no. 102 of Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the Chinese GMP re-certification.
In March Dawnrays Pharma participated in the “Chinese Hypertension Intervention Efficacy Study” (“CHIEF” Study) under the National Science and Technology Pillar Program of China’s “Eleventh Five-year Plan” and was appointed as the designated supplier for the research drugs.
In March Dawnrays Pharma established Guangdong Dawnrays Pharmaceutical Co., Ltd. in Guangzhou as a commercial platform for its pharmaceutical trading business.
In June Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd. held a ground-breaking ceremony in Nantong, Jiangsu Province to lay the foundation stone of its new chemical plant.
In October A piece of land at approximately 111 mu was newly acquired by Suzhou Dawnrays Pharmaceutical Co., Ltd. in Hedong Industrial Park, Wuzhong Economic Development District, Suzhou.
In November Dawnrays Pharma held the fourth training camp for Managers.
Year 2006

According to statistics from the “Pharmaceutical Industry Bulletin” issued by China Pharmaceutical Industry Association in 2006, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 42nd spot in terms of total profit as an individual entity.

In April

Construction of a new warehouse of Suzhou Dawnrays Pharmaceutical Co., Ltd. which covers a construction area of approximately 4,100 m2 was completed and was under operation.

In May

Suzhou Dawnrays Chemical Co., Ltd. has successfully passed the examination and attestation on three major Management System as conducted by American Quality Assessors International, LLC (AQA International, LLC), an accredited organization in the United States.

In June Construction of a pilot production workshop of Suzhou Dawnrays Chemical Co., Ltd. was completed and was under operation.
In June

The re-construction project for re-location and expansion of sterile bulk medicine workshops no. 101 and 102 of Suzhou Dawnrays Pharmaceutical Co., Ltd. was fixed.

In November Dawnrays Pharma held the third training camp for Managers.
In December

Re-construction of a workshop for cephalosporin tablets of Suzhou Dawnrays Pharmaceutical Co., Ltd. was completed.

In December Dawnrays (Nantong) Pharmaceutical Science and Technology Co., Ltd. was invested by the Group and established in Nantong, Jiangsu Province. A piece of land at approximately 130 mu (about 8.7 hectares) was acquired for a new project.
Year 2005

According to statistics from the “Pharmaceutical Industry Bulletin” issued by China Pharmaceutical Industry Association in 2005, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 28th spot in terms of total profit as an individual entity.

In May

Mr. JIN Hailong, Mayor of Wuzhong District, Suzhou together with other senior executives visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.

In July

The new sterile bulk medicine workshop no. 104 and the workshop no. 102 which incorporated a new product Cefuroxime Sodium of Suzhou Dawnrays Pharmaceutical Co., Ltd., passed the GMP certification from the State Food and Drug Administration (SFDA).

In September Dawnrays Pharma participated in the planning of the Wuzhong District Charity Federation and Ms. LI Kei Ling, the company's Chairman was served as the council member of the first council.
In October

Dawnrays Pharma held the second training camp for Managers.

In December

Dawnrays Pharma organized a series of activities for its tenth anniversary celebration.

In December Mr. YAN Li and Mr. ZHAO Junsheng, Mayor and Deputy Mayor of Suzhou respectively, together with other senior executives made an inspection tour to Suzhou Dawnrays Chemical Co., Ltd. with respect to the safety of the production work.
Year 2004

According to statistics from the “China Pharmaceutical Statistics Report 2003” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 31st and the 13th spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

In May

Mr. LI Quanlin, Deputy Governor of Jiangsu Province visited Suzhou Dawnrays Pharmaceutical Co., Ltd.

In June

Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the GMP re-inspection.

In July Mr. YU Guangzhou, Vice Minister of Commerce visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.
In September

Mr. Wu Changrui, Mr. WANG Daowu, Mr. JIANG Wentao and Mr. WANG Qi from the Jiangsu Science and Technology Committee of Chinese People's Political Consultative Conference and other committee members visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for an inspection tour.

In October

Dawnrays Pharma held the first training camp for Managers.

In December Party cadres from the Government of Yinzhou District, Ningbo, Zhejiang Province visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for an investigation tour.
Year 2003

According to statistics from the “China Pharmaceutical Statistics Report 2002” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 69th and the 26th spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

On July 11th Dawnrays Pharmaceutical (Holdings) Ltd. was successfully listed on the Main Board of the Stock Exchange of Hong Kong. Suzhou Dawnrays Pharmaceutical Co., Ltd. as a core subsidiary of Dawnrays Pharma, being the first enterprise in Suzhou, as well as the first pharmaceutical enterprise in Jiangsu Province listed on the Main Board of the Stock Exchange of Hong Kong.
On July 25th

Dawnrays Pharma held a press release conference in Dong Shan Hotel for the successful IPO of Dawnrays Pharmaceutical (Holdings) Ltd. on the Main Board of the Stock Exchange of Hong Kong.

On August 23rd According to the Market Information page of “China Pharmaceutical News”, Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 83rd spot among the nation's top 100 pharmaceutical industrial enterprises in terms of product sales income for the first half of the year 2003.
In October

Mr. WANG Min, member of the Standing Committee of Jiangsu Province and the Party Secretary of the Suzhou Municipal Committee, visited Suzhou Dawnrays Pharmaceutical Co., Ltd.

In November

Mr. YANG Weize, Mayor of Suzhou, visited Suzhou Dawnrays Pharmaceutical Co., Ltd. for investigation and study.

In December Suzhou Dawnrays Pharmaceutical Co., Ltd. increased its share capital to the registered amount of USD 25 million.
Year 2002

According to statistics from the “China Pharmaceutical Statistics Report 2001” (Pharmaceutical Chemical section), Suzhou Dawnrays Pharmaceutical Co., Ltd. was ranked at the 128th and the 41st spots among the nation's top 400 pharmaceutical enterprises in the Pharmaceutical Chemical section of individual entities in terms of sales income and total profit respectively.

In October

Phase II of the construction project of Suzhou Dawnrays Pharmaceutical Co., Ltd. has initiated with the estimated total capital expenditure of USD 19 million.

In December

Dawnrays Pharma invested USD 1.7 million to register as a solely foreign-invested enterprise named Suzhou Dawnrays Chemical Co., Ltd. in Wuzhong Economic Development District of Suzhou.

Year 1998
In January Suzhou Dawnrays Pharmaceutical Co., Ltd. was granted the GMP certificate.
In April Suzhou Dawnrays Pharmaceutical Co., Ltd. started its trial production.
In August Suzhou Dawnrays Pharmaceutical Co., Ltd. donated RMB 1 million worth of the first batch of pharmaceutical products to the frontline of the flood fight.
In August

Suzhou Dawnrays Pharmaceutical Co., Ltd. obtained 8 production permits for its pharmaceutical products, such as Cefoperazone Sodium for Injection and Cetirizine Hydrochloride Tablets, etc. Sales network and team were developed.

Year 1997
In October

Phase I of the construction project of Suzhou Dawnrays Pharmaceutical Co., Ltd. was completed.

In December

Dawnrays Pharma funded to establish Sino-foreign joint venture – Shanghai Dawnrays Chemical Co., Ltd.

In December

Suzhou Dawnrays Pharmaceutical Co., Ltd. successfully passed the overall inspection for GMP certification of pharmaceutical products conducted by the State Food and Drug Administration (SFDA).

Year 1995
On December 8th

Suzhou Dawnrays Pharmaceutical Co., Ltd. was founded and being issued with a Corporate Legal Person Business License.